Entities / Company
Voyager Therapeutics (United States).
company in Cambridge, United States
- Reports this week
- 0
- Active events
- 0
- Connections
- 22
What's happening
Gone quiet
No new reports in 90+ days-
Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.Some support2 reports
-
Voyager Therapeutics is expanding its Alzheimer's disease franchise with a program focused on modulating APOE using TRACER technology.Some support1 report
-
Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.Some support1 report
-
Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Connections
The 1 strongest of 22, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Todd Carter Structural
Todd Carter holds the position of Chief Scientific Officer at Voyager Therapeutics.
History
Events by the month they beganJune 2026
4 events- Voyager Therapeutics participated in a conference in Boston, MA, on August 26, 2025, involving Baird and programs derived from the TRACER AAV platform.
- Voyager Therapeutics is expanding its Alzheimer's disease franchise with a program focused on modulating APOE using TRACER technology.
- Voyager Therapeutics (United States) belongs to the biomedical and genetics industry.
- Alfred W. Sandrock, Jr. was appointed as the Chief Executive Officer of Voyager Therapeutics on August 7, 2025.